We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

10 Years of Revolutionizing Cardiac Care for Pets

SAVAVET celebrated a decade of SAFEHEART (Pimobendan chewable tablets) that has been transforming the treatment landscape for dogs with congestive heart failure (CHF) in India. Developed by SAVAVET, SAFEHEART has extended and enriched the lives of countless pets, allowing them to share more precious moments with their families.  

To mark this significant milestone, SAVAVET has launched a four-month heartcare campaign dedicated to raising awareness about CHF and promoting early diagnosis and effective management. This initiative spans key cities—Bengaluru, Chennai, Delhi, and Mumbai—and aims to reach over 500 veterinarians and pet parents.  

Campaign Highlights
– Cardiology Summit 2024: A landmark event featuring renowned veterinary cardiologists from India and abroad, including Dr. Gerhard Wess, Head of Cardiology Service at LMU, Munich. The summit explored advancements in the diagnosis and treatment of CHF and myxomatous mitral valve disease (MMVD), which accounts for over 70% of canine heart conditions.  
– Educational Outreach: Distribution of informative materials to veterinary clinics.
– Digital Empowerment: Launch of a user-friendly symptom checker on the SAVAVET website equipped with QR codes for pet parents to easily access CHF symptoms and the importance of early intervention to aid in recognizing heart disease symptoms early.  

As we celebrate this remarkable decade of innovation and compassion, SAVAVET continues to partner with the veterinary community to shape the future of small animal cardiology in India. Together, we look forward to many more years of healthier hearts and happier pets.